Costagliola D - Search Results

1

HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.

Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, Poizot-Martin I, Rouveix E, Engels EA, Costagliola D, Goedert JJ; FHDH-ANRS CO4. Lanoy E, et al. Among authors: costagliola d. Blood. 2011 Jul 7;118(1):44-9. doi: 10.1182/blood-2011-02-339275. Epub 2011 May 6. Blood. 2011. PMID: 21551234 Free PMC article.

2

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.

Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Heard I, et al. Among authors: costagliola d. AIDS. 1998 Aug 20;12(12):1459-64. doi: 10.1097/00002030-199812000-00007. AIDS. 1998. PMID: 9727566

3

Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.

Katlama C, Valantin MA, Matheron S, Coutellier A, Calvez V, Descamps D, Longuet C, Bonmarchand M, Tubiana R, De Sa M, Lancar R, Agut H, Brun-Vezinet F, Costagliola D. Katlama C, et al. Among authors: costagliola d. Ann Intern Med. 1998 Oct 1;129(7):525-31. doi: 10.7326/0003-4819-129-7-199810010-00003. Ann Intern Med. 1998. PMID: 9758571

4

Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

Magierowska M, Theodorou I, Debré P, Sanson F, Autran B, Rivière Y, Charron D, Costagliola D. Magierowska M, et al. Among authors: costagliola d. Blood. 1999 Feb 1;93(3):936-41. Blood. 1999. PMID: 9920843 Free article.

5

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

Grabar S, Pradier C, Le Corfec E, Lancar R, Allavena C, Bentata M, Berlureau P, Dupont C, Fabbro-Peray P, Poizot-Martin I, Costagliola D. Grabar S, et al. Among authors: costagliola d. AIDS. 2000 Jan 28;14(2):141-9. doi: 10.1097/00002030-200001280-00009. AIDS. 2000. PMID: 10708284 Clinical Trial.

6

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D. Salmon-Céron D, et al. Among authors: costagliola d. AIDS. 2000 May 26;14(8):1041-9. doi: 10.1097/00002030-200005260-00017. AIDS. 2000. PMID: 10853987 Clinical Trial.

7

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L. Grabar S, et al. Among authors: costagliola d. Ann Intern Med. 2000 Sep 19;133(6):401-10. doi: 10.7326/0003-4819-133-6-200009190-00007. Ann Intern Med. 2000. PMID: 10975957

8

Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy. The AI454-147 Team.

Kazatchkine MD, Van PN, Costagliola D, Mohammed AS, Ledeine JM, Troccaz M, Belec L. Kazatchkine MD, et al. Among authors: costagliola d. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):418-24. doi: 10.1097/00126334-200008150-00003. J Acquir Immune Defic Syndr. 2000. PMID: 11035612 Clinical Trial.

9

Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.

Abgrall S, Matheron S, Le Moing V, Dupont C, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Abgrall S, et al. Among authors: costagliola d. J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):151-8. doi: 10.1097/00042560-200102010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11242182

10

HIV incidence estimates among women of childbearing age in the area around Paris, France: no evidence for any effect of age or time.

Goubar A, Costagliola D. Goubar A, et al. Among authors: costagliola d. J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):492-8. doi: 10.1097/00126334-200108150-00011. J Acquir Immune Defic Syndr. 2001. PMID: 11511827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters